Amstutz, U <br/><br/>
HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Jul 2013 
 - 142-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2013.55  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Anticonvulsants--adverse effects<br/>Carbamazepine--adverse effects<br/>Child<br/>Child, Preschool<br/>Drug Eruptions--etiology<br/>Drug Hypersensitivity--etiology<br/>Female<br/>Genetic Markers<br/>Genetic Predisposition to Disease<br/>Genotyping Techniques<br/>HLA-A Antigens--genetics<br/>HLA-B15 Antigen--genetics<br/>Humans<br/>Infant<br/>Male<br/>Stevens-Johnson Syndrome--chemically induced<br/>Young Adult